Therapy of Systemic Rheumatic Disorders

Pathogenic Mechanisms as Targets for Therapy in Rheumatoid Arthritis, N. J. Zvaifler
Clinical Assessments in Rheumatoid Arthritis, Piet L. C. M. van Riel, Anke M. van Gestel, Maarten Boers, and David L. Scott
Prognostic Markers for Rheumatoid Arthritis, Michael J. Green, Charles Richardson, and Paul Emery
Clinical Trials Revisited, Harold E. Paulus and Ken J. Bulpitt
Second-line Agent Treatment: When and Whom, David L. Scott
Aggressive Treatment of Rheumatoid Arthritis: When, Whom, and How, Graciela S. Alarcón
Hydroxychloroquine, Howard Bird and Ann W. Morgan
D-Penicillamine, Howard Bird and Ann W. Morgan
Gold Therapy, Anne McEntegart and Hillary A. Capell
Sulfasalazine, Maxime Dougados
Methotrexate, Michael Ahern
Newer Second-line Agents: Cyclosporin, Theresa Podrebarac and Peter Tugwell
Cytotoxics (Azathioprine, Chlorambucil, and Cyclophosphamide), Philip J. Clements
Combination Disease-modifying Antirheumatic Drug Therapy, H. James Williams
When to Stop Second-line Drugs: Risk/Benefit Ratio of Continuation Versus Cessation in Patients with Rheumatoid Arthritis in Remission, S. ten Wolde and B. A. C. Dijkmans
Do Corticosteroids Have a Disease-modifying Role in Rheumatoid Arthritis?, Keith Lim and John R. Kirwan
Biological Agents Directed Against Cell Surface Antigens in the Treatment of Rheumatoid Arthritis, Ferdinand C. Breedveld
The Clinical Application of Cytokine Blockade in the Therapy of Rheumatoid Arthritis, Diana Davis, Michael J. Elliott, and Ravinder N. Maini
Local Therapy for Inflammatory Arthritis, John Edmonds
Antibiotic Treatment of Rheumatoid Arthritis, Christopher G. Jackson

Other Polyarthritides

Management of Spondylarthropathy, Maxime Dougados, Michel Revel, and Muhammad Asim Khan
Therapy of Systemic Rheumatic Disorders in Children, Anne-Marie Prieur
Palindromic Rheumatism and Recurrent Arthritis, Pierre-Andrè Guerne
Adult Still's Disease, Pierre-Andrè Guerne

Collagen Vascular Diseases

Systemic Lupus Erythematosus, Naomi F. Rothfield and Ann Parke
Therapy of Systemic Sclerosis, Carol Mary Black and Christopher P. Denton
Eosinophilic Fasciitis and Eosinophilia-Myalgia Syndrome, Daniel J. Clauw
Collagen Vascular Diseases: Polymyositis, Dermatomyositis, and Inclusion Body Myositis, Robert F. Spiera and Lawrence Kagen
Taxonomy of the Vasculitis Syndromes, C. G. M. Kallenberg
Therapy of Wegener's Granulomatosis, C. G. M. Kallenberg
Therapy of Other Vasculitis Syndromes, George D. Kitas, Paul A. Bacon, and Raashid Luqmani
Therapy of Sjögren's Syndrome, Panayiotis G. Vlachoyiannopoulos and Haralampos M. Moutsopoulos
Management of the Antiphospholipid Syndrome, E. Nigel Harris
Second-line Agents in Rheumatic Diseases During Pregnancy, Dafna D. Gladman and Gideon Koren
Cytotoxic Drugs and the Risk for Malignancies, Grant W. Cannon